Pancreatic Ductal Adenocarcinoma
📧 Sign up to get email alerts when something new happens for Pancreatic Ductal Adenocarcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-12-16Clinical Trial Update: TTFields and Chemotherapy in Metastatic Pancreatic Adenocarcinoma (mPDAC) [Phase 1, Phase 2]
A clinical trial update indicates that Tumor Treating Fields (TTFields) combined with chemotherapy is being studied in metastatic pancreatic…
-
CLINICAL_TRIALS research · 2025-12-11Clinical Trial Update: A Study of MT-4561 in Patients With Various Advanced Solid Tumors [Phase 1, Phase 2]
This trial update reports that MT-4561 is being studied in multiple advanced solid tumors across Phase 1/Phase 2 and is currently recruiting…
-
CLINICAL_TRIALS research · 2025-12-08Clinical Trial Update: PULSAR in Systemic Therapy for Pancreatic Cancer [Phase 2]
Phase 2 clinical trial (PULSAR) evaluating systemic therapy for pancreatic ductal adenocarcinoma is currently recruiting.
-
CLINICAL_TRIALS research · 2025-12-05Clinical Trial Update: A Phase II Clinical Study of HLX22 in Combination With Trastuzumab and Chemotherapy [Phase 2]
Phase II clinical trial evaluating HLX22 in combination with trastuzumab and chemotherapy for HER2-positive metastatic pancreatic ductal ade…
-
CLINICAL_TRIALS research · 2025-12-04Clinical Trial Update: Multi-agent Low Dose Chemotherapy GAX-CI Followed by Olaparib and Pembro in Metastatic Pancreatic Ductal Cancer. [Phase 2]
Phase 2 clinical trial evaluating a sequential regimen of GAX-CI chemotherapy followed by Olaparib and pembrolizumab in metastatic pancreati…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-12-02Clinical Trial Update: A Study of GFH375 Combined With Cetuximab or Chemotherapy in Participants With Solid Tumors Harboring KRAS G12D Mutation [Phase 1, Phase 2]
This is a Phase 1/2 clinical trial update evaluating GFH375 in combination with cetuximab or chemotherapy for KRAS G12D-mutant solid tumors,…
-
CLINICAL_TRIALS research · 2025-12-02Clinical Trial Update: Prognostic Outcomes of Total Mesopancreas Excision for Pancreatic Head Cancer [NA]
Clinical trial update on the prognostic outcomes of total mesopancreas excision for pancreatic head cancer; the study is currently recruitin…
-
CLINICAL_TRIALS research · 2025-11-28Clinical Trial Update: Using Strength Tests to Better Understand How Pancreatic Cancer Affects Muscle Mass and Quality of Life [NA]
A clinical trial investigates whether strength tests, including hand grip strength, can better characterize how pancreatic ductal adenocarci…
-
CLINICAL_TRIALS research · 2025-11-28Clinical Trial Update: EUS RFA for Treatment of Pancreatic Ductal Adenocarcinoma (PDAC) [Phase 1]
Phase 1 clinical trial evaluating endoscopic ultrasound-guided radiofrequency ablation for pancreatic ductal adenocarcinoma is currently rec…
-
CLINICAL_TRIALS research · 2025-11-26Clinical Trial Update: A Noninvasive and Screening miRNA Signature for Gastrointestinal Cancer
This clinical trial update describes a noninvasive miRNA-based test being explored for screening gastrointestinal cancers. It is currently r…
-
CLINICAL_TRIALS research · 2025-11-26Clinical Trial Update: Study Of Gemcitabine, Nab-paclitaxel, PEGPH20 and Rivaroxaban for Advanced Pancreatic Adenocarcinoma [NA]
Update on an ongoing study evaluating gemcitabine, nab-paclitaxel, PEGPH20, and rivaroxaban in advanced pancreatic ductal adenocarcinoma; th…
-
CLINICAL_TRIALS research · 2025-11-26Clinical Trial Update: PRetreatment MRI for OCcult Liver Metastasis Assessment In Pancreatic Ductal adenocarcinoMa
A clinical trial evaluating pre-treatment MRI to detect occult liver metastasis in pancreatic ductal adenocarcinoma is currently recruiting …
-
CLINICAL_TRIALS research · 2025-11-24Clinical Trial Update: A Study of GV20-0251 in Advanced or Refractory Solid Tumors [Phase 1]
This Phase 1 clinical trial update indicates that GV20-0251 is being studied in advanced or refractory solid tumors and is currently recruit…
-
CLINICAL_TRIALS research · 2025-11-21Clinical Trial Update: Austrian Registry for Evaluation of Treatment Patterns and Outcome in Patients With Advanced Pancreatic Ductal Adenocarcinoma (PDAC)
A registry-based study in Austria is recruiting to evaluate treatment patterns and outcomes in patients with advanced pancreatic ductal aden…
-
CLINICAL_TRIALS research · 2025-11-21Clinical Trial Update: Prediction of Neoadjuvant Chemotherapy Response in Pancreatic Cancer
ClinicalTrials.gov record describing a recruiting study at City of Hope Medical Center to predict how pancreatic ductal adenocarcinoma respo…
-
CLINICAL_TRIALS research · 2025-11-21Clinical Trial Update: Early Recurrence After Surgery for Pancreatic Cancer
An ongoing ClinicalTrials.gov study is examining early recurrence after pancreatic cancer surgery (pancreatic ductal adenocarcinoma) and is …
-
CLINICAL_TRIALS research · 2025-11-19Clinical Trial Update: Lenvatinib and Pembrolizumab Maintenance Therapy for the Treatment of Patients of Advanced Unresectable Pancreatic Cancer [Phase 2]
A Phase 2 trial is evaluating maintenance therapy with lenvatinib and pembrolizumab for advanced unresectable pancreatic cancer. The study i…
-
CLINICAL_TRIALS research · 2025-11-18Clinical Trial Update: A Phase II Clinical Study Evaluating SSGJ-706 in Combination Therapy for Advanced Gastrointestinal Cancers [Phase 2]
Phase II clinical study evaluating SSGJ-706 in combination therapy for advanced gastrointestinal cancers is not yet recruiting. The study in…
-
CLINICAL_TRIALS research · 2025-11-17Clinical Trial Update: HRS-4642 Combined With Nimotuzumab in the Treatment of Recurrent or Metastatic Pancreatic Ductal Adenocarcinoma [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating HRS-4642 in combination with nimotuzumab for recurrent or metastatic pancreatic ductal adenocarcinoma …
-
CLINICAL_TRIALS research · 2025-11-12Clinical Trial Update: Hyperpolarized 13C MRI to Predict Response in Pancreatic Cancer
A UC San Francisco-backed clinical trial is evaluating whether hyperpolarized 13C MRI can predict response to therapy in pancreatic ductal a…
-
CLINICAL_TRIALS research · 2025-11-12Clinical Trial Update: Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS [Phase 1, Phase 2]
A Phase 1/Phase 2 study evaluating RMC-6236 in patients with advanced solid tumors harboring RAS mutations, including non-small cell lung ca…
-
CLINICAL_TRIALS research · 2025-11-04Clinical Trial Update: Spevatamig (PT886) as Monotherapy or in Combination With Chemo and/or ICI, for the Treatment of Patients With Advanced Gastric, Gastroesophageal Junction, Pancreatic Ductal or Biliary Tract Carcinomas (the TWINPEAK Study) [Phase 1, Phase 2]
Spevatamig (PT886) is being studied as a monotherapy or in combination with chemotherapy and/or immune checkpoint inhibitors in Phase 1/2 tr…
-
CLINICAL_TRIALS research · 2025-10-29Clinical Trial Update: Adaptive Radiation for Locally Advanced Unresectable Pancreatic Cancer [NA]
An ongoing clinical trial is evaluating adaptive radiation therapy for locally advanced, unresectable pancreatic ductal adenocarcinoma and i…
-
CLINICAL_TRIALS research · 2025-10-21Clinical Trial Update: Study to Evaluate the Diagnostic Performance of GEH300079 (68Ga) Injection PET/CT for Detection of PC in Patients With Colorectal, Gastric, Ovarian, or Pancreatic Cancers (PERISCOPE) [Phase 2, Phase 3]
A Phase 2/3 trial evaluating the diagnostic performance of GEH300079 (68Ga) PET/CT for detecting pancreatic cancer in patients with colorect…
-
CLINICAL_TRIALS research · 2025-10-20Clinical Trial Update: 24BRO681 : Alternating Gnp and mFOLFIRINOX for BR-PDAC [Phase 2]
Phase 2 trial evaluating alternating gemcitabine/nab-paclitaxel and modified FOLFIRINOX in BRCA-related pancreatic ductal adenocarcinoma.